philipn / C21 (drug) 907711a180307a6b5b481b1f3d5baf59c964cbe6

Create Draft
Oral
Review changes View this version of the page
You can also use the and keys
Deletions are marked like this Additions are marked like this

C21, also known as VP01 or "Compound 21," is an agonist of the AT2 receptor currently in development by Vicore Pharma.  C21 is being trialed as a drug to treat COVID-19.

See also

C21, also known as VP01 or "Compound 21," is an agonist of the AT2 receptor currently in development by Vicore Pharma.  C21 is being trialed as a drug to treat COVID-19.

C21 is an oral, small molecule drug.

See also
Create Draft
Contributed by
Except where otherwise noted, text content is licensed under a Creative Commons Attribution-ShareAlike License. See copyright information.